Vigilant Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Vigilant Capital Management, LLC

  • $1.34 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 17, 2020
SELL
$336.18 - $494.43 $13,447 - $19,777
-40 Closed
0 $0
Q4 2019

Jan 17, 2020
BUY
$274.13 - $376.51 $10,965 - $15,060
40 New
40 $15,000
Q1 2019

Apr 09, 2019
SELL
$372.08 - $439.57 $8,185 - $9,670
-22 Closed
0 $0
Q4 2018

Jan 15, 2019
BUY
$335.82 - $403.04 $7,388 - $8,866
22 New
22 $8,000

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Vigilant Capital Management, LLC Portfolio

Follow Vigilant Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email